Crossref
Advances in inhalable formulations for cystic fibrosis treatment
SCIENTIA SINICA Vitae · 01.11.2026 · 56 (11) · 2481-2500
DOI: 10.1360/ssv-2026-0140 ↗Kurz gefasst
Fachartikel in der Zeitschrift SCIENTIA SINICA Vitae, online erschienen am 04.11.2026. Verfasst von Yue ZHOU und 4 weiteren Autor:innen. Die Arbeit nennt 137 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
ZHOU, Y., WANG, G., CHEN, C., WU, C., & ZHANG, X. (2026). Advances in inhalable formulations for cystic fibrosis treatment. SCIENTIA SINICA Vitae, 56(11), 2481-2500. https://doi.org/10.1360/ssv-2026-0140
Vancouver
ZHOU Y, WANG G, CHEN C, WU C, ZHANG X. Advances in inhalable formulations for cystic fibrosis treatment. SCIENTIA SINICA Vitae. 2026;56(11):2481-2500. doi:10.1360/ssv-2026-0140
BibTeX
@article{ZHOU2026,
author = {ZHOU, Yue and WANG, GuanLin and CHEN, ChuangXin and WU, ChuanBin and ZHANG, XueJuan},
title = {Advances in inhalable formulations for cystic fibrosis treatment},
journal = {SCIENTIA SINICA Vitae},
year = {2026},
volume = {56},
number = {11},
pages = {2481--2500},
doi = {10.1360/ssv-2026-0140}
}
EUVIMED